More possible good news.
Another option in the news to potentially combat the hyper-immune response (“cytokine storm”) seen in some of the Corona Virus patients.
CORONAVIRUS STUDY TO LOOK AT USING GOUT DRUG TO PREVENT LUNG COMPLICATIONS AND DEATHS FROM COVID-19
BY KASHMIRA GANDER ON 3/24/20 AT 12:26 PM EDT
Scientists in Canada have launched a study to test a drug they hope could prevent people from dying of lung complications caused by the respiratory disease COVID-19.
Researchers at the Montreal Heart Institute aim to recruit 6,000 COVID-19 patients for their COLCORONA study, according to a statement. The drug, called colchicine, is an anti-inflammatory pill used to treat gout, Behcet’s syndrome —which causes blood vessel inflammation— and the genetic disorder Familial Mediterranean Fever, where people have a recurrent abnormal body temperature.
Professor Jean-Claude Tardif, director of the Research Centre at the Montreal Heart Institute, told Radio Canada his team believes the medication could stop what is known as a cytokine storm, where the immune system overreacts. . . .